Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 23;12:531–539. doi: 10.2147/CMAR.S232632

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The expression of BRMS1L was regulated by transcription of CBP/p300. (A) CBP/p300 siRNAs were transfected into TE-1D cells and the effective silence of CBP/p300 was determined by qRT-PCR.(B and C) Overexpression of CBP/p300 in ECA-109 was evaluated by qRT-PCRand Western blot. (D) silence of CBP/p300 reduced BRMS1L expression level. (E) Overexpression of CBP/p300 increased BRMS1L expression level. (F and G) Modulation of CBP/p300 influenced BRMS1L promoter activity determined by luciferase reporter assay. (H and I) The correlation between BRMS1L and CBP/p300 mRNA levels were evaluated using the public database. n=3, **P < 0.01, ***P < 0.001, compared to NC/Vector.